Improvement of Libman-Sacks Endocarditis With Combined Hydroxychloroquine-Vitamin K Antagonist Therapy in a Primary Antiphospholipid Syndrome Patient

Received October 11, 2017; revised manuscript received January 15, 2018; accepted January 23, 2018; released online February 22, 2018 Time for primary review: 40 days Vascular Medicine Department (L.O., V.J., G.M.), Rennes University Hospital Center (L.O., V.J., G.M.), Rennes University, Rennes; MITOVASC Institute, Angers University, Angers (L.O., A.C., F.R., T.-H.M., C.B); Department of Vascular Medicine, Redon Hospital Center, Redon (L.O.); Department of Cardiology (A.C., F.R., T.-H.M.), Vascular and Coagulation Center (C.B.), Angers University Hospital Center, Angers; Department of Cardiovascular Investigations, Nantes University Hospital Center, Nantes (T.L.T.); and Thorax Institute, Nantes University, Nantes (T.L.T.), France Mailing address: Loukman Omarjee, MD, MSc, Vascular Medicine Department, Pôle Imagerie Médicale et Explorations Fonctionnelles, Univ Rennes, CHU Rennes, INSERM, CIC 1414, 2 rue Henri Le Guilloux, Rennes, F-35033, France. E-mail: loukmano@yahoo.fr ISSN-1346-9843 All rights are reserved to the Japanese Circulation Society. For permissions, please e-mail: cj@j-circ.or.